集体知情的注意力框架,增强糖尿病的进展预测
Changting Sheng1, Luyao Wang1, Caiyi Long1
1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Frontiers in endocrinology
|July 9, 2024
概括
这项研究利用深度学习增强了糖尿病 (DM) 进展预测. 它解决了不完整的数据,并提高了模型的稳定性,以更好地管理糖尿病.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 计算生物学 计算生物学
背景情况:
- 糖尿病是一种日益严重的全球健康问题,需要准确的进展预测.
- 深度学习提供了先进的预测能力,但面临着不完整数据和模型稳定性的挑战.
研究的目的:
- 通过深度学习提高糖尿病进展预测的精度和可靠性.
- 解决不完整数据的挑战,提高DM研究中的预测模型的稳定性.
主要方法:
- 利用针对性归算策略,在患者集群中寻找缺失的数据.
- 实现了数据增强和组级特征分析,以实现模型稳定性.
- 开发了一种对群体特征敏感的深度注意力变压器,用于处理各种临床数据.
主要成果:
- 深度注意力变压器模型使用临床和体检数据准确预测DM进展.
- 该模型执行高级特征选择和推理,识别关键的个人和团体级因素.
- 在糖尿病进展预测中证明了提高精度和可靠性.
结论:
- 开发的深度学习框架显著提升了糖尿病进展预测.
- 提供了对影响DM进展的因素的更深入的见解,有助于管理和研究.
- 突出了注意力转换器在处理复杂的医疗保健数据以预测慢性疾病方面的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Pathophysiology of Diabetes
917
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
917
Oral Hypoglycemic Agents: Biguanides and Glitazones
187
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
187


